Hostname: page-component-8448b6f56d-c47g7 Total loading time: 0 Render date: 2024-04-25T01:42:22.361Z Has data issue: false hasContentIssue false
  • English
  • Français

A New Distinction between the Euphoric and the Anti-Depressant Effects of Methylamphetamine

Published online by Cambridge University Press:  29 January 2018

S. A. Checkley
S. A. Checkley*
Affiliation:
Institute of Psychiatry, De Crespigny Park, London SE5
Get access Rights & Permissions [Opens in a new window]

Summary

The psychological effects of an injection of methylamphetamine have been measured in 22 drug-free patients with endogenous depressive illness and in 9 patients with other psychiatric illness. A new distinction between the time course of the euphoric and anti-depressant effects is described. The euphoric effects were seen in the first hour after the injection, but the anti-depressant effects were delayed for 1–3 hours and then lasted for as long as 36 hours. These findings are at variance with the noradrenaline depletion hypothesis of depressive illness which (in its simplest form) predicts an immediate alleviation of depression as a result of an immediate rise in the concentration of noradrenaline at central receptor sites.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 133 , Issue 5 , November 1978 , pp. 416 - 423
Copyright
Copyright © Royal College of Psychiatrists, 1978 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bond, A. J. & Lader, M. H. (1973) The residual effects of flurazepam. Psychopharmacologia (Berl.), 32, 223–35.CrossRefGoogle ScholarPubMed
Bond, A. J. & Lader, M. H. (1974) The use of analogue scales in rating subjective feelings. British Journal of Medical Psychology, 47, 211–18.Google Scholar
Carney, M. W. P., Roth, M. & Garside, R. F. (1965) The diagnosis of depressive syndromes and the prediction of ECT reponse. British Journal of Psychiatry, 111, 659–74.Google Scholar
Checkley, S. A. & Crammer, J. L. (1977) Hormone responses to methylamphetamine in depression: a new approach to the noradrenaline depletion hypothesis. British Journal of Psychiatry, 131, 582–6.Google Scholar
Delay, J. D. (1949) Pharmacological explorations of the personality: narcoanalysis and methedrine shock. Proceedings of the Royal Society of Medicine, 42, 491–6.Google Scholar
Estler, C. J. (1975) Effect of amphetamine-type psychostimulants on brain metabolism. Advances in Pharmacology and Therapeutics, 13, 305–57.CrossRefGoogle ScholarPubMed
Goodwin, F. K., Murphy, D. L., Brodie, H. K. H. & Bunney, W. E. (1970) L-DOPA catecholamines and behaviour: a clinical and biochemical study in depressed patients. Biological Psychiatry, 2, 341–66.Google ScholarPubMed
Gottlieb, J. S., Bobbitt, F. S. & Friedinger, A. W. (1950) Psychopharmacologic study of schizophrenia and depressions. VI. Differences in response to sodium amytal and benzedrine sulphate. Psychosomatic Medicine, 14, 104–14.Google Scholar
Hamilton, M. (1967) Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology, 6, 278–96.CrossRefGoogle ScholarPubMed
Johnsson, L. E., Anggard, E. & Gunne, L. M. (1971) Blockade of intravenous amphetamine Euphoria in Man. Clinical Pharmacology and Therapeutics, 12, 889–96.Google Scholar
Jonas, D. (1954) The adjunctive use of intravenous amphetamine derivative in psychotherapy. Journal of Nervous and Mental Disease, 119, 135–47.CrossRefGoogle ScholarPubMed
Kiloh, L. G., Neilson, M. & Andrews, G. (1974) Response of depressed patients to methylamphetamine. British Journal of Psychiatry, 125, 496–9.CrossRefGoogle ScholarPubMed
Lasagna, L., von Felsinger, J. M. & Beecher, H. K. (1955) Drug-induced mood changes in man. I. Observations on healthy subjects, chronically ill patients and ‘post-addicts’. Journal of the American Medical Association, 157, 1006–20.Google Scholar
Levine, J., Rinkel, M. & Greenblatt, M. (1948) Psychological and physiological effects of intravenous pervitin.CrossRefGoogle Scholar
Liddell, D. W. & Weil-Malherbe, H. (1953) The effects of methedrine and lysergic acid diethylamide on mental processes and on blood adrenaline level. Journal of Neurology, Neurosurgery and Psychiatry, 16, 7–13.CrossRefGoogle ScholarPubMed
Martin, W. R., Sloan, J. W., Sapira, J. D. & Jasinski, D. R. (1971) Physiologic, subjective and behavioural effects of amphetamine, methamphetamine, ephedrine, phenmetrazine and methylphenidate in man. Clinical Pharmacology, and Experimental Therapeutics, 12, 245–58.Google ScholarPubMed
Moore, K. E. (1977) The actions of amphetamines on neurotransmitters: a brief review. Biological Psychiatry, 12, 451–62.Google Scholar
Murphy, D. L. & Goodwin, F. K. (1972) The ‘switch process’ in manic-depressive illness. I. A systematic study of sequential behaviour changes. Archives of General Psychiatry, 27, 245–302.Google Scholar
Myerson, A. (1936) Effect of benzedrine sulphate on mood and fatigue in normal and in neurotic persons. Archives of Neurology and Psychiatry, 36, 816–22.CrossRefGoogle Scholar
Nathanson, M. H. (1937) The central action of betaaminopropylbenzene (Benzedrine). Clinical observations. Journal of the American Medical Association, 108, 528–31.CrossRefGoogle Scholar
Norris, H. (1971) The action of sedatives on brain stem occulomotor systems in man. Neuropharmacology, 10, 181–91.Google Scholar
Pelton, E. W. & Chase, T. N. (1975) L-DOPA and the treatment of extrapyramidal disease. Advances in Pharmacology and Chemotherapy, 13, 253–304.Google Scholar
Pennes, H. H. (1954) Clinical reactions of schizophrenics to sodium amytal, pervitin hydrochloride, mescaline sulphate and D-lysergic acid diethyl-amide (LSD25). Journal of Nervous and Mental Disease, 119, 95–112.Google Scholar
Perris, C. (1975) The bipolar/unipolar dichotomy and the need for a consistent terminology. Neuropsychobiology, 1, 65–9.Google Scholar
Rees, L., Butler, P. W. P., Gosling, C. & Besser, G. M. (1970) Adrenergic blockade and the corticosteroid and growth hormone response to methylamphetamine. Nature, 228, 565–6.Google Scholar
Roberts, J. M. (1959) Prognostic factors in the electro-shock treatment of depressive states. II. The application of specific tests. Journal of Mental Science, 105, 703–13.Google Scholar
Rudolf, G. de M. (1956) The treatment of depression with methylamphetamine. Journal of Mental Science, 102, 358–63.Google Scholar
Shaw, D. M. (1977) The practical management of affective disorders. British Journal of Psychiatry, 130, 432–51.CrossRefGoogle ScholarPubMed
Simon, S. L. & Taube, H. (1946) A preliminary study on the use of methedrine in psychiatric diagnosis. Journal of Nervous and Mental Disease, 104, 593–6.Google Scholar
Smith, G. M. & Beecher, H. K. (1960) Amphetamine, secobarbital and athletic performance. II. Subjective evaluations of performances, mood states and physical states. Journal of the American Medical Association, 172, 1502–14.CrossRefGoogle ScholarPubMed
Stoddard, F. J., Post, R. M. & Bunney, W. E. (1977) Slow and rapid psychobiological alterations in a manic-depressive patient: clinical phenomenology. British Journal of Psychiatry, 130, 72–80.CrossRefGoogle Scholar
Van Kammen, D. P. & Murphy, D. L. (1975) Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatment. Psychopharmacologia (Berl.), 44, 215–24.CrossRefGoogle ScholarPubMed
Von Beckmann, H. & Heinemann, H. (1976) D-amphetamin beim manischen syndrom. Arzneimittel-forschung, 26, 1185–6.Google Scholar
Von Felsinger, J. M., Lasagna, L. & Beecher, H. K. (1955) Drug-induced mood changes in man. 2. Personality and reactions to drugs. Journal of the American Medical Association, 157, 1113–9.Google Scholar
Weissman, A., Koe, B. K. & Tenen, S. S. (1966) Amphetamine effects following inhibition of tyrosine hydroxylase. Journal of Pharmacology and Experimental Therapeutics, 151, 339–52.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.